PROSHARES MSCI TRANSFORMATIONAL CHANGES ETF ANEW 深 滬
等待開盤 09-10 09:30:00 美东时间
51.5193
+0.018
+0.03%
華盛通- 最 高51.5193
- 今 開51.5017
- 成交量 3股
- 最 低 51.5193
- 昨 收 51.5017
- 總市值 901.59万
- 52周最高 51.5193
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 37.3615
- 委 比 0.00%
- 總股本 17.50万
- 歷史最高 51.5193
- 量 比 0
- 振 幅 0.00%
- 歷史最低 27.4326
- 每 手 1
- 風險率 2.50%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股新股解读 ｜ ANEW Health（AVG.US）：非药物性疼痛管理龙头赴美IPO，全球扩张驱动增长新引擎
Anew Health（AVG.US）更新招股文件，计划以每股4至6美元的价格发行180万股普通股，并于纳斯达克资本市场上市。
09-02 23:30
Davos 2025: ETFs To Tackle Geopolitical, Climate, Cyber Risks
WEF's 2025 Global Risks Report highlights geopolitical tensions, climate change, and disinformation as major challenges. ETFs can help investors navigate these risks with defense, clean energy, and cybersecurity funds.
01-16 05:11
Anew Medical gets new finance chief
U.S.-based biotechnology company Anew Medical (NASDAQ:WENA) appointed Jeffrey LeBlanc as the company’s CFO, replacing the interim CFO, Edward Cong Wang who was the former CFO of Redwoods Acquisition C...
2024-08-19 17:57
ANEW Medical: Post-Merger Outlook Amidst Financial Changes
The latest announcement is out from ANEW Medical (WENA). Public ANEW, following...
2024-06-28 05:28
Why SPAC Redwoods Acquisition Shares Are Skyrocketing Friday?
Redwoods Acquisition shares surge after shareholders approve merger with Anew Medical, propelling the company's prospects amidst recent challenges.
2024-04-19 22:09
Redwoods Merger Partner ANEW Medical Announced A Patent In China For The Use Of ANEW's Klotho Protein And Klotho Gene Delivery And Expression Systems In The Treatment Of Cognition, Memory And Neurodegenerative Diseases
ANEW MEDICAL, INC. ("ANEW" or "the Company") (OTCPK: LEAS) a US-based biotechnology company ("ANEW") focused on developing cell and gene- based treatments to affect aging and age-related
2024-03-04 18:15
财报季即将开启，两只成长型ETF或可助投资者捞底科技股？
美股市场中，很多成长型的股票和ETF已经被压低至52周甚至多年低位交投，而即将到来的财报季还将带来更多的市场波动。 不过，研究表明，股市在熊市中平均跌幅将在3...
2022-07-08 10:28
